Cambridge scientists use machine learning to future-proof pandemic protection

Machine Learning


For decades, vaccine development has followed much the same pattern. That is, a dangerous virus emerged, scientists identified it, developed a vaccine, and raced to keep up with pathogen evolution.

Researchers at the University of Cambridge now think they may have found a way to turn that model on its head.

In what scientists describe as a world first, an artificial intelligence-designed vaccine has successfully completed its first safety tests in humans, raising hopes that future vaccines can protect not only against known viruses, but also against new variants and pathogens that have yet to emerge.

This breakthrough technology focuses on using AI to design what researchers call “superantigens,” key components of vaccines that train the immune system to recognize and fight infections. The technology aims to provide protection across an entire family of viruses, rather than targeting a single virus strain.

Shifting from reactive to preventive

Current vaccines are typically developed using existing versions of the virus. Although this approach has saved millions of lives, it also has limitations.

Viruses like influenza and SARS-CoV-2 mutate all the time, so scientists have to repeatedly update vaccines to keep up with new strains.

The Cambridge team chose a different path.

Importantly, those responses extended beyond SARS-CoV-2, the virus that causes Covid-19. Participants also developed an immune response to SARS and related bat coronaviruses, which scientists believe could jump from animals to humans in the future.

The findings, published in the Journal of Infection, are considered evidence that AI-designed vaccine components can be safely tested in humans.

Researchers caution that the immune responses observed so far are modest and that larger studies are needed before drawing conclusions about real-world protection.

Why scientists are excited

The importance of the study lies not so much in this particular coronavirus vaccine but in the platform behind it.

Traditional vaccine development often requires years of laboratory work to identify the right target. AI has the potential to analyze vast datasets more quickly and identify patterns that may not be obvious to human researchers.



Source link